TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Vitrolife Sweden AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
1,520,273
|
1,218,581
|
1,033,211 |
Financial expenses |
11,506
|
34
|
106 |
Earnings before taxes |
473,025
|
404,234
|
323,985 |
EBITDA |
520,751
|
405,169
|
336,917 |
Total assets |
1,220,632
|
888,132
|
704,169 |
Current assets |
1,050,100
|
635,923
|
435,979 |
Current liabilities |
106,566
|
98,412
|
102,076 |
Equity capital |
1,090,185
|
761,502
|
575,964 |
- share capital |
507
|
473
|
488 |
Employees (average) |
168
|
164
|
163 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
89.3%
|
85.7%
|
81.8% |
Turnover per employee |
9,049
|
7,430
|
6,339 |
Profit as a percentage of turnover |
31.1%
|
33.2%
|
31.4% |
Return on assets (ROA) |
39.7%
|
45.5%
|
46.0% |
Current ratio |
985.4%
|
646.2%
|
427.1% |
Return on equity (ROE) |
43.4%
|
53.1%
|
56.3% |
Change turnover |
215,226
|
216,422
|
228,654 |
Change turnover % |
16%
|
22%
|
28% |
Chg. No. of employees |
4
|
1
|
7 |
Chg. No. of employees % |
2%
|
1%
|
4% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.